Alerts will be sent to your verified email
Verify EmailBAFNAPH
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Bafna Pharmaceuticals Ltd specializes in manufacturing tablets, capsules, and oral syrups, focusing on prescription drugs for the global market. They offer contract manufacturing services and a wide range of pharmaceutical categories.
Bafna Pharma major competitors are Krebs Biochem.&Inds, Aarey Drugs & Pharma, Panchsheel Organics, IndoAmerican Advance, Murae Organisor, Syschem (India), Pharmaids Pharma.
Market Cap of Bafna Pharma is ₹194 Crs.
While the median market cap of its peers are ₹196 Crs.
Bafna Pharma seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.